- Roche - Doing now what patients need next
Roche publishes its First Quarter Results for 2025 Roche continues with good momentum in 2025 with 6% (CER) sales growth in the first quarter Commenting on the results, Roche CEO Thomas Schinecker said “We had a good start to the year with Group sales increasing and we achieved a number of important milestones ”
- About Roche
About Roche Since our founding over 125 years ago, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas Our commitment to our people,
- Careers at Roche | Roche jobs
At Roche, we embrace the unique power of each person to transform the lives of patients and society, regardless of age, beliefs, ability, identity, background, or language Explore a wide range of roles in Germany, Austria, and Switzerland, contributing to our mission of creating a healthier future for people worldwide
- Roche Pharmaceuticals
Roche Pharmaceuticals is focused on translating excellence in science into effective medicines for patients It combines cutting-edge research at in the US in Japan and over 250 partners worldwide with global scale and reach in clinical development, manufacturing and commercial operations Thanks to the Pharma Division's broad-based portfolio, Roche is one of the world's leading providers of
- Roche Diagnostics
Roche introduces vertical and overhead transportation, enabling crossing walkways, floor to floor transportation, splitting the solution across different work areas and much more Country Specific Labeling See country-specific product labeling for regulatory status
- Solutions - Roche
At Roche Diagnostics, we develop diagnostic tests, instruments and digital solutions with the power to transform healthcare for people around the globe Solutions Product Development Portfolio Discover our pipeline of Pharmaceutical and Diagnostics developments Discover more
- Roche | Roches Full-Year Results 2024
Roche has published its Full Year Results for 2024 prior to the opening of the Swiss Stock Exchange on Thursday, 30 January 2025
- Roche Diagnostics
Roche Diagnostics develops innovative products and services that address the prevention, diagnosis, monitoring, screening and treatment of diseases Jump To Content You appear to be using incognito private browsing mode or an ad blocker, which may adversely affect your experience on the site
|